CD8A and COVID-19: Here, we discovered that cross-reactive T cells targeting SARS-CoV were present in individuals who had recovered from COVID-19, and identified SARS-CoV-2 CD8<sup>+</sup> T cell epitopes spanning the major structural antigens.